Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published CasesReview Published on 2020-12-162022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] acute respiratory syndrome anti-CD20 treatment asked cardiovascular diseases Chronic diseases Coronavirus-2 COVID-19 described disease Disease-modifying therapies experience Healthcare system immunosuppressive therapy information invasive mortality rate Multiple multiple sclerosis non-invasive ventilation outcome pandemic participant Patient patients physician positive Protective reducing required review risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pandemic sclerosis substantial risk the cytokine storm the disease therapy with COVID-19 [DOI] 10.3390/jcm9124067 PMC 바로가기 [Article Type] Review
SARS-CoV-2 infection in an advanced rheumatoid arthritis patientCase Reports Published on 2020-12-012023-07-06 Journal: Apmis [Category] SARS, [키워드] COVID-19 immunosuppressive therapy rheumatoid arthritis. SARS-CoV-2 [DOI] 10.1111/apm.13080 PMC 바로가기 [Article Type] Case Reports
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish PopulationArticle Published on 2020-11-252022-10-31 Journal: Cancers [Category] COVID-19, [키워드] affected antineoplastic drugs Cancer cancer patient Cancer patients cancer treatment Care carried Characteristics Chemotherapy Cohort Confirmed COVID-19 infection coronavirus 2 coronavirus disease COVID-19 COVID-19 infection COVID-19-related symptoms diagnosed died disease evaluate Evolution First wave General population health emergency help higher risk hospital ICU immunosuppressive therapies immunosuppressive therapy Immunotherapy Impact impacted Infection information knowledge lack management material no significant difference outcome pandemic Patient patients patients hospitalized Patients with cancer performed Population positive Prevalence receiving required respiratory Retrospective analysis risk RT-PCR SARS-CoV-2 SARS-COV-2 infection Seroconversion seroconversion rate Seroprevalence simple Spanish Symptom targeted therapy tested the disease therapy Treatment [DOI] 10.3390/cancers12123513 PMC 바로가기 [Article Type] Article
Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experienceArticle Published on 2020-11-012023-07-12 Journal: European journal of cardio-thoracic surgery : official journal of the [Category] SARS, [키워드] Heart transplant population and coronavirus disease Heart transplant recipient immunosuppressive therapy Severe acute respiratory syndrome coronavirus 2. [DOI] 10.1093/ejcts/ezaa323 PMC 바로가기
Novel coronavirus infection and acute kidney injury in two renal transplant recipients: a case reportArticle Published on 2020-10-252023-06-15 Journal: The Journal of international medical research [Category] MERS, SARS, [키워드] Acute kidney injury Case report immunosuppressive therapy Methylprednisolone Novel coronavirus infection Pneumonia Renal transplantation [DOI] 10.1177/0300060520964009 PMC 바로가기
Successful recovery from coronavirus disease 2019 in a living kidney transplant recipient using low‐dose methylprednisoloneCase Report Published on 2020-10-052022-10-29 Journal: IJU Case Reports [Category] COVID-19, [키워드] Administered blood oxygen level C‐reactive protein coronavirus disease COVID‐19 Dyspnea Fever immunosuppressive Immunosuppressive agents immunosuppressive therapy kidney kidney transplant Kidney transplantation low‐dose methylprednisolone Lungs management Methylprednisolone Pneumonia polymerase chain positive Prevent recipient reducing severe coronavirus disease solid organ transplant Spread therapy tomography [DOI] 10.1002/iju5.12226 PMC 바로가기 [Article Type] Case Report
Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case reportCase Report Published on 2020-09-252022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, SARS, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus 2 Antiviral treatment Case report caused Clinical characteristics Clinical course clinical picture clinical presentation Clinical presentations combination therapy coronavirus disease Coronavirus disease 2019 courses COVID-19 COVID-19 infection disease spread had more Immunosuppression immunosuppressive immunosuppressive therapy management mild respiratory symptom multi-organ failure outcome Patient patients recipient reduced renal Renal transplant recipients severe pneumonia Spread therapy [DOI] 10.1186/s12879-020-05434-4 PMC 바로가기 [Article Type] Case Report
Wichtigste Impfungen bei Patienten mit rheumatologischen Erkrankungen und warumArticle Published on 2020-09-212023-07-01 Journal: Zeitschrift Fur Rheumatologie [Category] SARS, [키워드] herd immunity Immunität Immunity immunosuppressive therapy Immunsuppressive Therapie Impfung Infektionsrisiko Multidrug-resistant pathogen Rheumatische Erkrankungen risk of infection [DOI] 10.1007/s00393-020-00875-3 PMC 바로가기
Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?Review Published on 2020-09-212023-08-28 Journal: BMC Rheumatology [Category] E형 간염, [키워드] chronic hepatitis hepatitis E virus immunosuppressive therapy Rheumatic diseases Rheumatic manifestations [DOI] 10.1186/s41927-020-00149-0 PMC 바로가기 [Article Type] Review
Myasthenia Gravis and COVID-19: Clinical Characteristics and OutcomesNeurology Published on 2020-09-112022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] Autoimmune Brazil clinical conducted Course COVID-19 died disorder hospital Hospitalized Immunosuppression immunosuppressive therapy intensive care mechanical ventilation Most patient Myasthenia myasthenia gravis Neuromuscular disorders outcomes Patient plasma protective role Retrospective study risk factor Safe SARS-CoV-2 severe COVID-19 with COVID-19 [DOI] 10.3389/fneur.2020.01053 PMC 바로가기 [Article Type] Neurology